$3.61
-0.41 (-10.20%)
Open$3.89
Previous Close$4.02
Day High$3.89
Day Low$3.61
52W High$2,423.50
52W Low$253.30
Volume—
Avg Volume10.1K
Market Cap141.32M
P/E Ratio—
EPS$-6.28
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,006.6% upside
Current
$3.61
$3.61
Target
$39.95
$39.95
$34.56
$39.95 avg
$63.39
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.02B | 991.15M | 56.95M |
| Net Income | -130,056,854 | -113,829,785 | 10.61M |
| Profit Margin | -28.4% | -27.0% | 18.6% |
| EBITDA | -69,453,953 | -64,165,375 | 17.54M |
| Free Cash Flow | — | — | 14.62M |
| Rev Growth | +2.8% | +2.8% | -4.9% |
| Debt/Equity | 0.46 | 0.46 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |